Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.2.3.13SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.3.13SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.3.13EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.13NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.3.9ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.3.9ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.3.9SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.3.9SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BA.2.3.9EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.9NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.3.9NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.2.10.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BA.2.10.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BA.2.10.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.10.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BF.35ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
BF.35ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
BF.35SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.35SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
BF.35EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BF.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.35NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BF.35NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
CY.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
CY.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
CY.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CY.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
CY.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CY.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CY.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
CY.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FR.2ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-19758.2South Korea
FR.2ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
FR.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FR.2SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
FR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FR.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBJ.4ORF1abWon-ORF1abCATGTGTGGCGGTTCACTAT20501544115460F-22753.7South Korea
XBJ.4ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
XBJ.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBJ.4SWon-SCACCTGTGCCTGTTAAACCA20502321323194R-21965.9South Korea
XBJ.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBJ.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBJ.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
XBJ.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used